SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-237683
Filing Date
2021-08-05
Accepted
2021-08-05 16:02:26
Documents
14
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d157926d8k.htm   iXBRL 8-K 23821
2 EX-99.1 d157926dex991.htm EX-99.1 71848
6 GRAPHIC g157926g96v35.jpg GRAPHIC 2751
  Complete submission text file 0001193125-21-237683.txt   232017

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arvn-20210805.xsd EX-101.SCH 2888
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20210805_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20210805_pre.xml EX-101.PRE 11405
7 EXTRACTED XBRL INSTANCE DOCUMENT d157926d8k_htm.xml XML 3354
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 211148061
SIC: 2834 Pharmaceutical Preparations